Medac Pharma: Medac Pharma, Inc. Announces The Patent Trial And Appeal Board (PTAB) Upheld Patents On Rasuvo® (Single Dose Auto-Injection Of Methotrexate)

CHICAGO, Feb. 9, 2018 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company, today announced the PTAB has upheld all 22 claims of our parent company medac GmbH's patent covering its rheumatoid arthritis treatment, Rasuvo®, an auto-injector that provides highly...